ArticleRenal failure2025
Estimated pulse wave velocity and the risk of acute kidney injury in patients undergoing coronary revascularization: a retrospective cohort study from MIMIC-IV.
Article in Renal failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute kidney injury (AKI) commonly complicates coronary revascularization, worsening outcomes. Estimated pulse wave velocity (ePWV), a simple arterial stiffness marker, independently predicts cardiovascular risk. This study aimed to evaluate the association between ePWV and AKI in patients undergoing coronary revascularization. Based on the Medical Information Mart for Intensive Care (MIMIC)-IV database, this retrospective cohort study obtained the data of patients who underwent coronary revascularization, including percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). The ePWV was calculated based on the patients' age and blood pressure. Univariable and multivariable logistics regression were utilized to evaluate the association between ePWV and AKI in this population, with odds ratio (ORs) and 95% confidence intervals (CIs). Stratified analyses based on age, gender, surgery types, complications were further conducted to verify this association. This study ultimately included 2,842 eligible patients who underwent coronary revascularization. Among them, 1,174 (41.31%) occurred AKI. We observed high ePWV is associated with high risk of AKI in patients received coronary revascularization (OR = 1.36, 95%CI: 1.10-1.69). Similar results were also observed in patients who underwent CABG (OR = 1.08, 95%CI: 0.96-1.21), without the history of acute myocardial infarction (OR = 1.39, 95%CI: 1.06-1.82), or atrial fibrillation (OR = 1.36, 95%CI: 1.07-1.73), or with the history of hypertension (OR = 1.48, 95%CI: 1.12-1.95) or had higher estimated glomerular filtration rate (eGFR) level (OR = 1.45, 95%CI: 1.16-1.81). The results suggested high ePWV is associated with the high risk of AKI among patients underwent coronary revascularization. The ePWV is a simple and noninvasive indicator that could be used for risk stratification of AKI after coronary revascularization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.